Guerbet Stock price

Equities

GBT

FR0000032526

Advanced Medical Equipment & Technology

Real-time Euronext Paris 12:35:10 2024-03-28 pm EDT 5-day change 1st Jan Change
32.85 EUR -2.09% Intraday chart for Guerbet +7.88% +68.46%
Sales 2023 786M 847M Sales 2024 * 853M 919M Capitalization 415M 447M
Net income 2023 22M 23.71M Net income 2024 * 28M 30.18M EV / Sales 2023 0.31 x
Net Debt 2023 * 272M 294M Net Debt 2024 * 312M 337M EV / Sales 2024 * 0.85 x
P/E ratio 2023 *
42.8 x
P/E ratio 2024 *
14.8 x
Employees 2,839
Yield 2023 *
1.54%
Yield 2024 *
1.79%
Free-Float 42.95%
More Fundamentals * Assessed data
Dynamic Chart
1 day-2.09%
1 week+7.88%
Current month+9.50%
1 month+11.36%
3 months+68.81%
6 months+98.85%
Current year+68.46%
More quotes
1 week
32.60
Extreme 32.6
35.55
1 month
28.85
Extreme 28.85
35.55
Current year
17.02
Extreme 17.02
35.55
1 year
15.48
Extreme 15.48
35.55
3 years
15.28
Extreme 15.28
45.65
5 years
15.28
Extreme 15.28
57.20
10 years
15.28
Extreme 15.28
90.64
More quotes
Managers TitleAgeSince
Chief Executive Officer 55 18-01-31
Director of Finance/CFO - 19-03-31
Chief Tech/Sci/R&D Officer - -
Members of the board TitleAgeSince
Director/Board Member 51 17-05-18
Director/Board Member 61 23-05-25
Director/Board Member 64 14-05-22
More insiders
Date Price Change Volume
24-03-28 32.85 -2.09% 14,593
24-03-27 33.55 -2.04% 10,129
24-03-26 34.25 -3.52% 24,690
24-03-25 35.5 +4.26% 37,241
24-03-22 34.05 +11.82% 115,719

Real-time Euronext Paris, March 28, 2024 at 12:35 pm EDT

More quotes
Guerbet is a European leader in producing and selling contrast products for medical imaging. The group's products make it possible to visualize different organs and the lymphatic and vascular systems of the human body by making them opaque. Net sales break down by product family as follows: - X-ray imaging products (55.1%); - MRI products (32.9%); - other (12%): contrast products for echography and nuclear medicine, fine chemicals products. At the end of 2021 the group had 8 production sites located in France (4), the United States (2), Ireland and Brazil. Europe accounts for 40% of net sales.
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
B+
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
5
Last Close Price
32.85 EUR
Average target price
36.82 EUR
Spread / Average Target
+12.08%
Consensus

Quarterly revenue - Rate of surprise

  1. Stock
  2. Equities
  3. Stock Guerbet - Euronext Paris